Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$727M |
| 2 |
Home Depot
HD
|
+$472M |
| 3 |
Pfizer
PFE
|
+$362M |
| 4 |
Texas Instruments
TXN
|
+$314M |
| 5 |
LyondellBasell Industries
LYB
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$567M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$245M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$242M |
| 4 |
AT&T
T
|
+$170M |
| 5 |
Accenture
ACN
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
AerCap
AER
$23.8B
| $11.5M | ﹤0.01% |
228,540
+59,029
| +35% | +$3.54M |
|
1877
Flex
FLEX
$44.8B
| $11.5M | ﹤0.01% |
821,420
+119,425
| +17% | +$1.53M |
|
1878
Celldex Therapeutics
CLDX
$3.27B
| $11.5M | ﹤0.01% |
336,808
+8,713
| +3% | +$279K |
|
1879
CTS Corp
CTS
$1.89B
| $11.5M | ﹤0.01% |
324,022
+10,663
| +3% | +$373K |
|
1880
Magnite
MGNI
$3.55B
| $11.4M | ﹤0.01% |
866,706
+24,728
| +3% | +$333K |
|
1881
SkinHealth Systems
SKIN
$85.7M
| $11.4M | ﹤0.01% |
677,742
+21,963
| +3% | +$362K |
|
1882
Usana Health Sciences
USNA
$286M
| $11.4M | ﹤0.01% |
143,402
+8,654
| +6% | +$780K |
|
|
AAMI
1883
Acadian Asset Management
AAMI
$3.2B
| $11.4M | ﹤0.01% |
469,252
-44,365
| -9% | -$1.05M |
|
1884
Ryan Specialty Holdings
RYAN
$5.55B
| $11.3M | ﹤0.01% |
292,250
+9,128
| +3% | +$347K |
|
1885
Revolution Medicines
RVMD
$44B
| $11.3M | ﹤0.01% |
444,212
+13,134
| +3% | +$286K |
|
1886
Codexis
CDXS
$158M
| $11.3M | ﹤0.01% |
549,357
+97,365
| +22% | +$2.02M |
|
1887
Palomar
PLMR
$3.45B
| $11.3M | ﹤0.01% |
176,882
+5,848
| +3% | +$332K |
|
1888
FB Financial Corp
FBK
$3.04B
| $11.3M | ﹤0.01% |
253,956
+6,732
| +3% | +$301K |
|
1889
CorVel
CRVL
$3.19B
| $11.2M | ﹤0.01% |
199,791
+4,341
| +2% | +$247K |
|
|
EVA
1890
DELISTED
Enviva Inc.
EVA
| $11.2M | ﹤0.01% |
+141,120
| New | +$10.3M |
|
|
SWTX
1891
DELISTED
SpringWorks Therapeutics
SWTX
| $11.2M | ﹤0.01% |
197,624
+6,365
| +3% | +$364K |
|
1892
NeoGenomics
NEO
$2.13B
| $11.1M | ﹤0.01% |
917,183
+20,596
| +2% | +$433K |
|
1893
National Bank Holdings
NBHC
$1.9B
| $11.1M | ﹤0.01% |
276,288
+855
| +0.3% | +$38K |
|
|
AVYA
1894
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $11.1M | ﹤0.01% |
877,633
+4,878
| +0.6% | +$75.9K |
|
1895
BancFirst
BANF
$3.8B
| $11.1M | ﹤0.01% |
133,249
-189,715
| -59% | -$14.7M |
|
1896
Varex Imaging
VREX
$523M
| $11.1M | ﹤0.01% |
520,442
+63,690
| +14% | +$1.62M |
|
1897
Golar LNG
GLNG
$5.13B
| $11.1M | ﹤0.01% |
446,899
+14,637
| +3% | +$241K |
|
|
TVTY
1898
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $11.1M | ﹤0.01% |
344,252
+32,309
| +10% | +$874K |
|
1899
PJT Partners
PJT
$4.38B
| $11.1M | ﹤0.01% |
175,344
+4,491
| +3% | +$292K |
|
1900
Chefs' Warehouse
CHEF
$4.5B
| $11.1M | ﹤0.01% |
339,246
+9,466
| +3% | +$298K |
|
Similar funds
Charles Schwab's Q1 2022 Portfolio in Review
As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,782 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.
- Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
- Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
- Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
- Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
- Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
- Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.
Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.